vijaya bpc 157 BPC-157 VIAL - High-Purity Peptide for Research Andrew - Comment PEPTIDES &

Research outcomes should not be extrapolated to expected human results

For alignment with language in the preamble of the CY 2025 PFS proposed rule (89 FR 61954), we clarified at 427.402(b)(1) that CMS will apply a severe supply chain disruption rebate reduction to the applicable calendar quarter in which the event occurred or began, or the following applicable calendar quarter if the request is submitted less than 60 calendar days before the end of an applicable calendar quarter, and the 3 subsequent applicable calendar quarters

Comment: One commenter asked CMS to consider any interaction this proposal, to establish an add-on payment for take-home supplies of nalmefene, may have on treatments currently covered under Medicare Part D

The intercostal muscles, connective tissue, and often the cartilage connecting ribs to the sternum all sustain injury in thoracic trauma